Matricelf Ltd. has entered a strategic collaboration with Sheba Medical Center in Israel to conduct its first human clinical trial for spinal cord injury treatment using autologous engineered neural tissue. This partnership enables Matricelf to manufacture implants in Sheba's facility and leverage the center's integrated clinical and rehabilitation expertise. The trial marks Matricelf's shift from preclinical to clinical development, aiming to prove the therapy's effectiveness in humans. Positive safety data from animal studies support this progression, with the trial expected to streamline operations and accelerate timelines.
The 9th Shandong-South Korea Economic and Trade Cooperation Conference and South Korea Week took place in Yantai, China, starting November 6, 2026. Over 150 companies from both regions participated, signing 23 new cooperation projects across sectors ...
The 9th Shandong-South Korea Economic and Trade Cooperation Conference and Yantai South Korea Week opened on November 6 in Yantai, China, highlighting strong economic ties between the Shandong province and South Korea. Over 150 companies participated...
Snail, Inc., a leading independent game developer and publisher, announced that four of its indie games will be featured with playable demos at an exclusive event hosted by Noiz.gg during TwitchCon Weekend. The games include one already available on ...
Snail, Inc. announced it will showcase four games from its indie branch Wandering Wizard at an exclusive event during TwitchCon weekend hosted by Noiz.gg. The lineup includes the already Steam-available Death Party and three upcoming titles: Whispers...
The Rosen Law Firm has filed a class action lawsuit against NuScale Power Corporation for allegedly making false and misleading statements about its competitive advantage and revenue prospects between February 27 and September 10, 2026. Investors who...
